Issue 1/2020
Content (16 Articles)
Solid pavestones are needed to pave a solid way to success
Haidong Dong
Mechanisms of immune evasion in bladder cancer
Paul L. Crispen, Sergei Kusmartsev
Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody
Ryota Shibaki, Shuji Murakami, Yuji Matsumoto, Tatsuya Yoshida, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Nobuyuki Yamamoto, Masahiko Kusumoto, Noboru Yamamoto, Yuichiro Ohe
Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers
Tomohiro Kikuchi, Kosaku Mimura, Mai Ashizawa, Hirokazu Okayama, Eisei Endo, Katsuharu Saito, Wataru Sakamoto, Shotaro Fujita, Hisahito Endo, Motonobu Saito, Tomoyuki Momma, Zenichiro Saze, Shinji Ohki, Kazunori Shimada, Kiyoshi Yoshimura, Takuya Tsunoda, Koji Kono
VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
Liju Zong, Yuncan Zhou, Ming Zhang, Jie Chen, Yang Xiang
Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells
Yeni Romero, Randi Wise, Anna Zolkiewska
A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression
Richard Klar, Sven Michel, Monika Schell, Lisa Hinterwimmer, Alfred Zippelius, Frank Jaschinski
Interleukin-38 in colorectal cancer: a potential role in precision medicine
Feier Chen, Feng Zhang, Zhenyu Tan, Brett D. Hambly, Shisan Bao, Kun Tao
GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma
Aida Rashidi, Jason Miska, Catalina Lee-Chang, Deepak Kanojia, Wojciech K. Panek, Aurora Lopez-Rosas, Peng Zhang, Yu Han, Ting Xiao, Katarzyna C. Pituch, Julius W. Kim, Mahsa Talebian, Jawad Fares, Maciej S. Lesniak
Tailoring early-phase clinical trial design to address multiple research objectives
Nolan A. Wages, Craig L. Slingluff Jr., Timothy N. Bullock, Gina R. Petroni
CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1
Nuray Erin, Sayra Dilmaç, Anna Curry, Özlem Duymuş, Gamze Tanriover, Aaron Prodeus, Jean Gariepy, Reginald M. Gorczynski
IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment
Chunyan Yu, Xiulong Niu, Yongrui Du, Yan Chen, Xiaomei Liu, Lingling Xu, Yoichiro Iwakura, Xiaoxia Ma, Yan Li, Zhi Yao, Weimin Deng
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer
Yuki Ozaki, Satoshi Muto, Hironori Takagi, Masayuki Watanabe, Takuya Inoue, Mitsuro Fukuhara, Takumi Yamaura, Naoyuki Okabe, Yuki Matsumura, Takeo Hasegawa, Jun Ohsugi, Mika Hoshino, Yutaka Shio, Daisuke Tanaka, Hideaki Nanamiya, Jun-ichi Imai, Takao Isogai, Shinya Watanabe, Hiroyuki Suzuki
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Rui Zhang, Fengjiao Yuan, Yang Shu, Yaomei Tian, Bailing Zhou, Linglu Yi, Xueyan Zhang, Zhenyu Ding, Heng Xu, Li Yang
Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer
Johanna Waidhauser, Anja Schuh, Martin Trepel, Ann-Kristin Schmälter, Andreas Rank
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Nadia Mensali, Marit Renée Myhre, Pierre Dillard, Sylvie Pollmann, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli, Else Marit Inderberg